Invesco Ltd. - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 84 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$21,000
-60.4%
11,238
+0.8%
0.00%
Q4 2021$53,000
-53.9%
11,151
-29.6%
0.00%
Q3 2021$115,000
-11.5%
15,843
+12.6%
0.00%
Q2 2021$130,000
-67.4%
14,071
-41.4%
0.00%
Q2 2020$399,000
+60.2%
24,005
+9.9%
0.00%
Q1 2020$249,00021,8500.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 2,291,133$1,166,1871.01%
Privium Fund Management (UK) Ltd 117,200$59,6550.04%
Redmile Group, LLC 1,850,566$941,9380.04%
Baker Brothers Advisors 3,821,740$1,945,2660.01%
Kynam Capital Management, LP 120,764$61,4690.01%
Sio Capital Management, LLC 38,312$19,5010.01%
SIMON QUICK ADVISORS, LLC 46,856$23,8500.00%
Tri Locum Partners LP 10,248$5,0000.00%
Endurance Wealth Management, Inc. 20,000$100.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$38,1750.00%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders